Survivorship: Life with Long-Term Surveillance

Meningioma care is often a lifelong journey. Because these tumors can recur many years—sometimes a decade or more—after treatment, long-term surveillance is the standard of care ^[1][2]. Transitioning from active treatment to “survivorship” means shifting your focus to quality of life, seizure management, and a regular rhythm of monitoring.

The Rhythm of Surveillance

The frequency of your MRI scans depends on your tumor’s WHO grade and the Simpson grade (the completeness of its removal) ^[3][4]. While every center is different, common guidelines recommend the following:

• WHO Grade 1 (Benign): After an initial scan 4 months post-surgery, you may move to annual MRIs ^[3]. If the tumor was completely removed and remains stable for a decade or more, your clinical team may discuss adjusting the frequency, though many prefer to continue monitoring indefinitely due to the risk of late recurrence ^[3][1].
• WHO Grade 2 (Atypical): Annual MRIs are typically recommended indefinitely, as the risk of the tumor returning is higher than with Grade 1 ^[3].
• WHO Grade 3 (Anaplastic): Monitoring is much more frequent—often every 3–4 months for the first two years, then every 6 months indefinitely ^[3].
• Incomplete Removal: If any part of the tumor was left behind, indefinite monitoring is necessary regardless of the grade ^[3].

A Note on Gadolinium

Gadolinium is the “contrast dye” used to make tumors “light up” on an MRI. Over many years of surveillance, some patients worry about the cumulative effects of these injections. Research suggests that for some stable meningiomas, non-contrast T2-weighted or FLAIR imaging can be a valid way to measure the tumor’s size while avoiding gadolinium ^[5]. You can ask your doctor if your tumor is a candidate for a non-contrast “fast” MRI protocol.

Quality of Life and “Scanxiety”

Living between scans can be psychologically taxing. This phenomenon is often called scanxiety—the period of intense worry that occurs before and after an imaging appointment ^[6].

• Managing Uncertainty: Quality of life is often impacted more by the perception of a threat than the tumor itself ^[6]. Open communication with your team and finding support groups can help ground your experience.
• Cognitive Health: Even “asymptomatic” survivors may experience subtle challenges with memory, verbal learning, or “brain fog” ^[7][8]. Identifying these early can help you find rehabilitation strategies to improve daily functioning.

Seizure Management

Seizures are one of the most significant factors affecting quality of life for meningioma survivors ^[9].

• Surgical Impact: The good news is that many patients who experience seizures before surgery find that their seizures improve or disappear once the tumor and the surrounding swelling (edema) are gone ^[10][11].
• Long-Term Control: If seizures persist, they are often managed with anti-seizure medications. Factors that increase the risk of ongoing seizures include higher tumor grade, tumor recurrence, or specific areas of brain irritation seen on an MRI ^[12].
• Safety First (Driving Restrictions): It is critical to know that experiencing a seizure, or sometimes simply undergoing brain surgery, often results in a mandatory, temporary suspension of your driver’s license. The exact duration depends on local laws and your medical team’s assessment. This is a massive quality-of-life disruption, so it is important to plan ahead for transportation with your support system.

While the “watchful” part of survivorship never truly ends for many, most meningioma survivors live full, active lives by integrating these check-ups into their routine and staying proactive about their physical and mental health ^[13].

Return to Home | Previous: Emerging Therapies